Company attributes
Location
B2X
CEO
Founder
Legal Name
Xeno Biosciences Inc.
Legal classification
Number of Employees (Ranges)
1 – 10
Full Address
411A HIGHLAND AVENUE #341, SOMERVILLE, MA, 02144
CIK Number
Investors
Total Funding Amount (USD)
2,050,000
Latest Funding Round Date
June 2019
Latest Funding Type
Patents Assigned (Count)
1
Other attributes
Company Operating Status
Active
Xeno Biosciences is a clinical-stage company led by a team, dedicated to developing transformational therapies for metabolic diseases. The company is developing XEN-101, an investigational treatment for obesity.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
